These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 17312014

  • 1. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H, Matsuda K, Ochiai I, Kawauchi A, Mizutani Y, Miki T, Kawata M.
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [Abstract] [Full Text] [Related]

  • 2. Antiandrogens prevent stable DNA-binding of the androgen receptor.
    Farla P, Hersmus R, Trapman J, Houtsmuller AB.
    J Cell Sci; 2005 Sep 15; 118(Pt 18):4187-98. PubMed ID: 16141232
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker HC, Hanrahan S, Totty N, Gamble SC, Waxman J, Cato AC, Hurst HC, Bevan CL.
    Clin Cancer Res; 2004 Nov 01; 10(21):7392-401. PubMed ID: 15534116
    [Abstract] [Full Text] [Related]

  • 4. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N, Miyamoto H, Mizokami A, Harada S, Nomura M, Ueta Y, Sasaguri T, Matsumoto T.
    Cancer Invest; 2007 Feb 01; 25(1):32-7. PubMed ID: 17364555
    [Abstract] [Full Text] [Related]

  • 5. Studies of targeting and intracellular trafficking of an anti-androgen doxorubicin-formaldehyde conjugate in PC-3 prostate cancer cells bearing androgen receptor-GFP chimera.
    Cogan PS, Koch TH.
    J Med Chem; 2004 Nov 04; 47(23):5690-9. PubMed ID: 15509168
    [Abstract] [Full Text] [Related]

  • 6. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
    Marcelli M, Stenoien DL, Szafran AT, Simeoni S, Agoulnik IU, Weigel NL, Moran T, Mikic I, Price JH, Mancini MA.
    J Cell Biochem; 2006 Jul 01; 98(4):770-88. PubMed ID: 16440331
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y, Wolff DW, Lin MF, Tu Y.
    Mol Pharmacol; 2007 Jul 01; 72(1):73-85. PubMed ID: 17430995
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia increases androgen receptor activity in prostate cancer cells.
    Park SY, Kim YJ, Gao AC, Mohler JL, Onate SA, Hidalgo AA, Ip C, Park EM, Yoon SY, Park YM.
    Cancer Res; 2006 May 15; 66(10):5121-9. PubMed ID: 16707435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status.
    Wetherill YB, Fisher NL, Staubach A, Danielsen M, de Vere White RW, Knudsen KE.
    Cancer Res; 2005 Jan 01; 65(1):54-65. PubMed ID: 15665279
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
    Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J.
    Prostate; 2007 Feb 01; 67(2):178-89. PubMed ID: 17044040
    [Abstract] [Full Text] [Related]

  • 15. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
    Paris F, Rabeolina F, Balaguer P, Bacquet A, Sultan C.
    Gynecol Endocrinol; 2007 Apr 01; 23(4):193-7. PubMed ID: 17505938
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
    Horii K, Suzuki Y, Kondo Y, Akimoto M, Nishimura T, Yamabe Y, Sakaue M, Sano T, Kitagawa T, Himeno S, Imura N, Hara S.
    Mol Cancer Res; 2007 Apr 01; 5(4):383-91. PubMed ID: 17426252
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY, Cai C, Fisher CJ, Zheng Z, Omwancha J, Hsieh CL, Shemshedini L.
    Oncogene; 2006 Nov 16; 25(54):7212-23. PubMed ID: 16732317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.